237 related articles for article (PubMed ID: 15699399)
1. Predicting menstrual migraine with a home-use fertility monitor.
MacGregor EA; Frith A; Ellis J; Aspinall L
Neurology; 2005 Feb; 64(3):561-3. PubMed ID: 15699399
[TBL] [Abstract][Full Text] [Related]
2. Monitoring of ovarian activity by measurement of urinary excretion rates of estrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part II: reliability of home testing.
Blackwell LF; Vigil P; Gross B; d'Arcangues C; Cooke DG; Brown JB
Hum Reprod; 2012 Feb; 27(2):550-7. PubMed ID: 22131389
[TBL] [Abstract][Full Text] [Related]
3. Monitoring of ovarian activity by daily measurement of urinary excretion rates of oestrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part III: variability of normal menstrual cycle profiles.
Blackwell LF; Vigil P; Cooke DG; d'Arcangues C; Brown JB
Hum Reprod; 2013 Dec; 28(12):3306-15. PubMed ID: 24170744
[TBL] [Abstract][Full Text] [Related]
4. Personal hormone monitoring for contraception.
Bonnar J; Flynn A; Freundl G; Kirkman R; Royston R; Snowden R
Br J Fam Plann; 1999 Jan; 24(4):128-34. PubMed ID: 10023097
[TBL] [Abstract][Full Text] [Related]
5. Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen.
MacGregor EA; Frith A; Ellis J; Aspinall L; Hackshaw A
Neurology; 2006 Dec; 67(12):2154-8. PubMed ID: 16971700
[TBL] [Abstract][Full Text] [Related]
6. Determination of the time of ovulation in chimpanzees by measurement of LH, estrone sulfate, and pregnanediol 3 alpha-glucuronide in urine: comparison with serum hormone patterns.
Steinetz BG; Ducrot C; Randolph C; Mahoney CJ
J Med Primatol; 1992 Jul; 21(5):239-45. PubMed ID: 1404332
[TBL] [Abstract][Full Text] [Related]
7. Characterizing daily urinary hormone profiles for women at midlife using functional data analysis.
Meyer PM; Zeger SL; Harlow SD; Sowers M; Crawford S; Luborsky JL; Janssen I; McConnell DS; Randolph JF; Weiss G
Am J Epidemiol; 2007 Apr; 165(8):936-45. PubMed ID: 17267418
[TBL] [Abstract][Full Text] [Related]
8. A prospective multicentre study to develop universal immunochemical tests for predicting the fertile period in women. World Health Organisation Task Force on Methods for the Determination of the Fertile Period, Special Programme of Research, Development and Research Training in Human Reproduction.
Int J Fertil; 1985; 30(3):18-30. PubMed ID: 2867054
[TBL] [Abstract][Full Text] [Related]
9. Prediction of ovulation by urinary hormone measurements with the home use ClearPlan Fertility Monitor: comparison with transvaginal ultrasound scans and serum hormone measurements.
Behre HM; Kuhlage J; Gassner C; Sonntag B; Schem C; Schneider HP; Nieschlag E
Hum Reprod; 2000 Dec; 15(12):2478-82. PubMed ID: 11098014
[TBL] [Abstract][Full Text] [Related]
10. Timing clinic visits to phases of the menstrual cycle by using a fertility monitor: the BioCycle Study.
Howards PP; Schisterman EF; Wactawski-Wende J; Reschke JE; Frazer AA; Hovey KM
Am J Epidemiol; 2009 Jan; 169(1):105-12. PubMed ID: 18974081
[TBL] [Abstract][Full Text] [Related]
11. Prevention of menstrual attacks of migraine: a double-blind placebo-controlled crossover study.
MacGregor EA; Frith A; Ellis J; Aspinall L; Hackshaw A
Neurology; 2006 Dec; 67(12):2159-63. PubMed ID: 17190936
[TBL] [Abstract][Full Text] [Related]
12. Variability in the hormonally estimated fertile phase of the menstrual cycle.
Fehring RJ; Schneider M
Fertil Steril; 2008 Oct; 90(4):1232-5. PubMed ID: 18249381
[TBL] [Abstract][Full Text] [Related]
13. The validation of the Billings ovulation method by laboratory research and field trials.
Billings JJ
Acta Eur Fertil; 1991; 22(1):9-15. PubMed ID: 1746210
[TBL] [Abstract][Full Text] [Related]
14. High-tech family planning: reproductive regulation through computerized fertility monitoring.
Genuis SJ; Bouchard TP
Eur J Obstet Gynecol Reprod Biol; 2010 Dec; 153(2):124-30. PubMed ID: 20655652
[TBL] [Abstract][Full Text] [Related]
15. Prediction of ovulation with the assessment of LH and the E1G/P2G ratio in urinary samples.
Baviera G; Carroccio G; Scurria L; Pizzi V; Scarselli G
Acta Eur Fertil; 1988; 19(3):139-42. PubMed ID: 3067480
[TBL] [Abstract][Full Text] [Related]
16. Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition.
Hale GE; Hughes CL; Burger HG; Robertson DM; Fraser IS
Menopause; 2009; 16(1):50-9. PubMed ID: 18978637
[TBL] [Abstract][Full Text] [Related]
17. Side of ovulation and cycle characteristics in normally fertile women.
Ecochard R; Gougeon A
Hum Reprod; 2000 Apr; 15(4):752-5. PubMed ID: 10739814
[TBL] [Abstract][Full Text] [Related]
18. [Correlation between indicators of the fertile period of the menstrual cycle and ultrasonically-determined ovulation].
Croce P; Quarenghi A; Montanari G; Barbato M; Pravettoni G; Bertolotti G
Minerva Endocrinol; 1989; 14(3):147-52. PubMed ID: 2622425
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres.
Granella F; Sances G; Allais G; Nappi RE; Tirelli A; Benedetto C; Brundu B; Facchinetti F; Nappi G
Cephalalgia; 2004 Sep; 24(9):707-16. PubMed ID: 15315526
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous dosage of oestrone-3-glycuronide and pregnanediol-3-glycuronide in urines to monitor the fertile period in the woman.
Cortesi S; Fortunato A; Marzot E; Soffiati G
Acta Eur Fertil; 1991; 22(1):27-31. PubMed ID: 1746204
[No Abstract] [Full Text] [Related]
[Next] [New Search]
